296 related articles for article (PubMed ID: 19631619)
1. Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123.
Tai LM; Reddy PS; Lopez-Ramirez MA; Davies HA; Male DK; Loughlin AJ; Romero IA
Brain Res; 2009 Oct; 1292():14-24. PubMed ID: 19631619
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein.
Neuhaus W; Stessl M; Strizsik E; Bennani-Baiti B; Wirth M; Toegel S; Modha M; Winkler J; Gabor F; Viernstein H; Noe CR
Neurosci Lett; 2010 Jan; 469(2):224-8. PubMed ID: 19963040
[TBL] [Abstract][Full Text] [Related]
3. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.
Cucullo L; Couraud PO; Weksler B; Romero IA; Hossain M; Rapp E; Janigro D
J Cereb Blood Flow Metab; 2008 Feb; 28(2):312-28. PubMed ID: 17609686
[TBL] [Abstract][Full Text] [Related]
4. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
Feng B; Mills JB; Davidson RE; Mireles RJ; Janiszewski JS; Troutman MD; de Morais SM
Drug Metab Dispos; 2008 Feb; 36(2):268-75. PubMed ID: 17962372
[TBL] [Abstract][Full Text] [Related]
5. Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3.
Fasler-Kan E; Suenderhauf C; Barteneva N; Poller B; Gygax D; Huwyler J
Brain Res; 2010 Oct; 1354():15-22. PubMed ID: 20692239
[TBL] [Abstract][Full Text] [Related]
6. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
7. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H
J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789
[TBL] [Abstract][Full Text] [Related]
8. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line.
Boveri M; Berezowski V; Price A; Slupek S; Lenfant AM; Benaud C; Hartung T; Cecchelli R; Prieto P; Dehouck MP
Glia; 2005 Aug; 51(3):187-98. PubMed ID: 15800928
[TBL] [Abstract][Full Text] [Related]
9. Interaction of imatinib mesilate with human P-glycoprotein.
Hamada A; Miyano H; Watanabe H; Saito H
J Pharmacol Exp Ther; 2003 Nov; 307(2):824-8. PubMed ID: 12975485
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air-liquid interface method for nasal drug transport study.
Cho HJ; Choi MK; Lin H; Kim JS; Chung SJ; Shim CK; Kim DD
J Pharm Pharmacol; 2011 Mar; 63(3):385-91. PubMed ID: 21749386
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro.
Yang ZH; Liu XD
Epilepsy Res; 2008 Jan; 78(1):40-9. PubMed ID: 18063342
[TBL] [Abstract][Full Text] [Related]
12. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line.
Zastre JA; Chan GN; Ronaldson PT; Ramaswamy M; Couraud PO; Romero IA; Weksler B; Bendayan M; Bendayan R
J Neurosci Res; 2009 Mar; 87(4):1023-36. PubMed ID: 18855943
[TBL] [Abstract][Full Text] [Related]
14. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
15. Comparison of drug efflux transport kinetics in various blood-brain barrier models.
Bachmeier CJ; Trickler WJ; Miller DW
Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
He L; Zhao C; Yan M; Zhang LY; Xia YZ
Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664
[TBL] [Abstract][Full Text] [Related]
17. Functional expression and localization of P-glycoprotein at the blood brain barrier.
Bendayan R; Lee G; Bendayan M
Microsc Res Tech; 2002 Jun; 57(5):365-80. PubMed ID: 12112443
[TBL] [Abstract][Full Text] [Related]
18. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
Ohtsuki S; Ikeda C; Uchida Y; Sakamoto Y; Miller F; Glacial F; Decleves X; Scherrmann JM; Couraud PO; Kubo Y; Tachikawa M; Terasaki T
Mol Pharm; 2013 Jan; 10(1):289-96. PubMed ID: 23137377
[TBL] [Abstract][Full Text] [Related]
19. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier.
Hsiao P; Bui T; Ho RJ; Unadkat JD
Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117
[TBL] [Abstract][Full Text] [Related]
20. In vitro models for the blood-brain barrier.
Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T
Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
